Literature DB >> 31801144

Waiting List and Kidney Transplant Vascular Risk: An Ongoing Unmet Concern.

Domingo Hernández1, Juana Alonso-Titos2, Ana Maria Armas-Padrón3, Veronica Lopez2, Mercedes Cabello2, Eugenia Sola2, Laura Fuentes2, Elena Gutierrez2, Teresa Vazquez2, Tamara Jimenez2, Pedro Ruiz-Esteban2, Miguel Gonzalez-Molina2.   

Abstract

BACKGROUND: Chronic kidney disease (CKD) is an important independent risk factor for adverse cardiovascular events in patients waitlisted for kidney transplantation (KT). Although KT reduces cardiovascular risk, these patients still have a higher all-cause and cardiovascular mortality than the general population. This concerning situation is due to a high burden of traditional and nontraditional risk factors as well as uremia-related factors and transplant-specific factors, leading to 2 differentiated processes under the framework of CKD, atherosclerosis and arteriosclerosis. These can be initiated by insults to the vascular endothelial endothelium, leading to vascular calcification (VC) of the tunica media or the tunica intima, which may coexist. Several pathogenic mechanisms such as inflammation-related endothelial dysfunction, mineral metabolism disorders, activation of the renin-angiotensin system, reduction of nitric oxide, lipid disorders, and the fibroblast growth factor 23-klotho axis are involved in the pathogenesis of atherosclerosis and arteriosclerosis, including VC.
SUMMARY: This review focuses on the current understanding of atherosclerosis and arteriosclerosis, both in patients on the waiting list as well as in kidney transplant recipients, emphasizing the cardiovascular risk factors in both populations and the inflammation-related pathogenic mechanisms. Key Message: The importance of cardiovascular risk factors and the pathogenic mechanisms related to inflammation in patients waitlisted for KT and kidney transplant recipients.
© 2019 The Author(s) Published by S. Karger AG, Basel.

Entities:  

Keywords:  Arteriosclerosis; Atheromatosis; Cardiovascular disease; Chronic kidney disease; Kidney transplantation; Mortality; Vascular calcification; Waiting-list

Mesh:

Year:  2019        PMID: 31801144      PMCID: PMC7649689          DOI: 10.1159/000504546

Source DB:  PubMed          Journal:  Kidney Blood Press Res        ISSN: 1420-4096            Impact factor:   2.687


  20 in total

1.  Renal replacement therapy for acute renal failure.

Authors:  P Murray; J Hall
Journal:  Am J Respir Crit Care Med       Date:  2000-09       Impact factor: 21.405

2.  Factors determining a low dose of haemodialysis as measured by ionic dialysance in critical patients with acute kidney injury.

Authors:  Guillermo Rosa-Diez; Gustavo Greloni; María Crucelegui; Mariela Bedini-Roca; Agustina Heredia-Martínez; M Luisa Coli; Sergio Giannasi; Eduardo San-Román; Rodolfo Pizarro; César Belzitti; Salomón Algranati; Ricardo Heguilen
Journal:  Nefrologia       Date:  2012-04-17       Impact factor: 2.033

Review 3.  Acute kidney injury from sepsis: current concepts, epidemiology, pathophysiology, prevention and treatment.

Authors:  Sadudee Peerapornratana; Carlos L Manrique-Caballero; Hernando Gómez; John A Kellum
Journal:  Kidney Int       Date:  2019-06-07       Impact factor: 10.612

4.  A randomized clinical trial of high volume peritoneal dialysis versus extended daily hemodialysis for acute kidney injury patients.

Authors:  D Ponce; M N Berbel; J M G Abrão; C R Goes; A L Balbi
Journal:  Int Urol Nephrol       Date:  2012-10-12       Impact factor: 2.370

5.  High volume peritoneal dialysis vs daily hemodialysis: a randomized, controlled trial in patients with acute kidney injury.

Authors:  D P Gabriel; J T Caramori; L C Martim; P Barretti; A L Balbi
Journal:  Kidney Int Suppl       Date:  2008-04       Impact factor: 10.545

Review 6.  Prolonged Intermittent Renal Replacement Therapy.

Authors:  Fahad Edrees; Tingting Li; Anitha Vijayan
Journal:  Adv Chronic Kidney Dis       Date:  2016-05       Impact factor: 3.620

Review 7.  Fluid overload in the ICU: evaluation and management.

Authors:  Rolando Claure-Del Granado; Ravindra L Mehta
Journal:  BMC Nephrol       Date:  2016-08-02       Impact factor: 2.388

8.  EPILAT-IRA Study: A contribution to the understanding of the epidemiology of acute kidney injury in Latin America.

Authors:  Raúl Lombardi; Alejandro Ferreiro; Rolando Claure-Del Granado; Emmanuel A Burdmann; Guillermo Rosa-Diez; Luis Yu; Mauricio Younes-Ibrahim; Cristina Carlino; Jonathan S Chávez-Iñiguez; Mariana B Pereira; Carlos F Varela; Welder Zamoner; Diego Janiques; Soledad Lecueder; Víctor Cerrón-Millán; Alfonso Cueto-Manzano
Journal:  PLoS One       Date:  2019-11-14       Impact factor: 3.240

9.  Kidney involvement in COVID-19 and rationale for extracorporeal therapies.

Authors:  Claudio Ronco; Thiago Reis
Journal:  Nat Rev Nephrol       Date:  2020-06       Impact factor: 28.314

10.  Clinical Characteristics of Coronavirus Disease 2019 in China.

Authors:  Wei-Jie Guan; Zheng-Yi Ni; Yu Hu; Wen-Hua Liang; Chun-Quan Ou; Jian-Xing He; Lei Liu; Hong Shan; Chun-Liang Lei; David S C Hui; Bin Du; Lan-Juan Li; Guang Zeng; Kwok-Yung Yuen; Ru-Chong Chen; Chun-Li Tang; Tao Wang; Ping-Yan Chen; Jie Xiang; Shi-Yue Li; Jin-Lin Wang; Zi-Jing Liang; Yi-Xiang Peng; Li Wei; Yong Liu; Ya-Hua Hu; Peng Peng; Jian-Ming Wang; Ji-Yang Liu; Zhong Chen; Gang Li; Zhi-Jian Zheng; Shao-Qin Qiu; Jie Luo; Chang-Jiang Ye; Shao-Yong Zhu; Nan-Shan Zhong
Journal:  N Engl J Med       Date:  2020-02-28       Impact factor: 91.245

View more
  2 in total

1.  Optimizing Decellularization Strategies for the Efficient Production of Whole Rat Kidney Scaffolds.

Authors:  Panagiotis Mallis; Charalampos Oikonomidis; Zetta Dimou; Catherine Stavropoulos-Giokas; Efstathios Michalopoulos; Michalis Katsimpoulas
Journal:  Tissue Eng Regen Med       Date:  2021-05-20       Impact factor: 4.169

Review 2.  Renal Delivery of Pharmacologic Agents During Machine Perfusion to Prevent Ischaemia-Reperfusion Injury: From Murine Model to Clinical Trials.

Authors:  Rossana Franzin; Alessandra Stasi; Marco Fiorentino; Simona Simone; Rainer Oberbauer; Giuseppe Castellano; Loreto Gesualdo
Journal:  Front Immunol       Date:  2021-07-06       Impact factor: 7.561

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.